These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 19671808

  • 1. Bisphosphonates in patients with glucocorticoids: time for implementation.
    Lems WF.
    J Rheumatol; 2009 Aug; 36(8):1570-2. PubMed ID: 19671808
    [No Abstract] [Full Text] [Related]

  • 2. Glucocorticoid-induced osteoporosis: prevention and treatment.
    Werth VP.
    Rev Rhum Engl Ed; 1997 Jun 30; 64(6 Suppl):84S-88S. PubMed ID: 9273946
    [No Abstract] [Full Text] [Related]

  • 3. [Glucocorticoids in rheumatic diseases - what is the optimal dose?].
    Krause D.
    Dtsch Med Wochenschr; 2012 Sep 30; 137(36):1751-4. PubMed ID: 22933199
    [Abstract] [Full Text] [Related]

  • 4. [Osteoporosis in rheumatic diseases: role of glucocrticoids (part I)].
    Nasonov EL, Skripnikova IA.
    Klin Med (Mosk); 1997 Sep 30; 75(10):12-8. PubMed ID: 9490330
    [No Abstract] [Full Text] [Related]

  • 5. Glucocorticoid-induced osteoporosis.
    Lukert BP, Raisz LG.
    Rheum Dis Clin North Am; 1994 Aug 30; 20(3):629-50. PubMed ID: 7984782
    [Abstract] [Full Text] [Related]

  • 6. [Pay attention to glucocorticoid-induced osteoporosis in treatment of rheumatic diseases].
    Zhang X.
    Zhonghua Nei Ke Za Zhi; 2008 May 30; 47(5):357-8. PubMed ID: 18953939
    [No Abstract] [Full Text] [Related]

  • 7. An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
    Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgström F, Cooper C, Perez AD, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE, Joint IOF–ECTS GIO Guidelines Working Group.
    Arch Osteoporos; 2012 May 30; 7():25-30. PubMed ID: 23225278
    [Abstract] [Full Text] [Related]

  • 8. Etidronate and glucocorticoid induced osteoporosis.
    Ortego-Centeno N, Muñoz-Torres M, Callejas-Rubio JL, Riera-Montes M.
    J Rheumatol; 2005 Jan 30; 32(1):199-200. PubMed ID: 15630758
    [No Abstract] [Full Text] [Related]

  • 9. Glucocorticoid-induced osteoporosis in inflammatory bowel disease.
    Lidofsky S, Smith J.
    Med Health R I; 2009 Apr 30; 92(4):128-30. PubMed ID: 19452756
    [Abstract] [Full Text] [Related]

  • 10. [Significance of cytokines for bone loss--are there possible interventions?].
    Scharla SH.
    Z Rheumatol; 2001 Apr 30; 60(2):104-6. PubMed ID: 11383043
    [No Abstract] [Full Text] [Related]

  • 11. Rheumatic disorders and glucocorticoid-induced osteoporosis.
    Dequeker J, Westhovens R, Luyten FP.
    Front Horm Res; 2002 Apr 30; 30():107-20. PubMed ID: 11892257
    [No Abstract] [Full Text] [Related]

  • 12. [Letter query to Zeitschrift für Rheumatologie by Dr. med. Ilka Schwarze FA of Internal Medicine and Rheumatology Center of Internal Medicine--Leipzig University Clinic].
    Scharla S.
    Z Rheumatol; 2005 Mar 30; 64(2):138-9. PubMed ID: 15793680
    [No Abstract] [Full Text] [Related]

  • 13. The epidemiology of glucocorticoid-associated adverse events.
    McDonough AK, Curtis JR, Saag KG.
    Curr Opin Rheumatol; 2008 Mar 30; 20(2):131-7. PubMed ID: 18349741
    [Abstract] [Full Text] [Related]

  • 14. A rapid, high content, in vivo model of glucocorticoid-induced osteoporosis.
    Barrett R, Chappell C, Quick M, Fleming A.
    Biotechnol J; 2006 Jun 30; 1(6):651-5. PubMed ID: 16892313
    [Abstract] [Full Text] [Related]

  • 15. [Frequency of side effects of glucocorticoid therapy in relation to the regimen for administering the hormonal preparations].
    Zaremba EF.
    Vrach Delo; 1984 Nov 30; (11):60-3. PubMed ID: 6396947
    [No Abstract] [Full Text] [Related]

  • 16. [Epidemiology of corticosteroid-induced osteoporosis].
    Braun J.
    Z Rheumatol; 2001 Apr 30; 60(2):107-10. PubMed ID: 11383044
    [No Abstract] [Full Text] [Related]

  • 17. Corticosteroid-induced osteoporosis.
    Legerton CW.
    J S C Med Assoc; 2001 Mar 30; 97(3):111-3. PubMed ID: 11285882
    [No Abstract] [Full Text] [Related]

  • 18. [Glucocorticoid-induced osteoporosis treatment algorithm].
    Payer J, Killinger Z, Brázdilová K.
    Vnitr Lek; 2009 May 30; 55(5):506-11. PubMed ID: 19514617
    [Abstract] [Full Text] [Related]

  • 19. Comorbidities: glucocorticoids and osteoporosis: predicting fracture risk.
    Cohen SB.
    Nat Rev Rheumatol; 2010 Dec 30; 6(12):681-2. PubMed ID: 21119717
    [No Abstract] [Full Text] [Related]

  • 20. [Interactions of salicylates and glucocorticoids in the combined treatment of rheumatic diseases].
    Gruchelska B.
    Pol Tyg Lek; 1980 Mar 03; 35(9):321-4. PubMed ID: 6966058
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.